-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2009 to 2023.
- Lifecore Biomedical, Inc. \De\ Depreciation, Depletion and Amortization for the quarter ending August 25, 2024 was $1.99M, a 8.07% decline year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2023 was $8.86M, a 32.8% decline from 2022.
- Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2022 was $13.2M, a 27% decline from 2021.
- Lifecore Biomedical, Inc. \De\ annual Depreciation, Depletion and Amortization for 2021 was $18.1M, a 9.09% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)